168 related articles for article (PubMed ID: 30946309)
1. A systematic review and meta-analysis of naproxen for prevention heterotopic ossification after hip surgery.
Zhang AH; Chen X; Zhao QX; Wang KL
Medicine (Baltimore); 2019 Apr; 98(14):e14607. PubMed ID: 30946309
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of naproxen prophylaxis for the prevention of heterotopic ossification after hip surgery: a meta-analysis.
Ma R; Chen GH; Zhao LJ; Zhai XC
J Orthop Surg Res; 2018 Mar; 13(1):48. PubMed ID: 29506541
[TBL] [Abstract][Full Text] [Related]
3. Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention of heterotopic ossification after total hip arthroplasty: A meta-analysis.
Zhu XT; Chen L; Lin JH
Medicine (Baltimore); 2018 Aug; 97(31):e11649. PubMed ID: 30075549
[TBL] [Abstract][Full Text] [Related]
4. The Effect of NSAID Prophylaxis and Operative Variables on Heterotopic Ossification After Hip Arthroscopy.
Beckmann JT; Wylie JD; Kapron AL; Hanson JA; Maak TG; Aoki SK
Am J Sports Med; 2014 Jun; 42(6):1359-64. PubMed ID: 24664136
[TBL] [Abstract][Full Text] [Related]
5. Effect of Naproxen Prophylaxis on Heterotopic Ossification Following Hip Arthroscopy: A Double-Blind Randomized Placebo-Controlled Trial.
Beckmann JT; Wylie JD; Potter MQ; Maak TG; Greene TH; Aoki SK
J Bone Joint Surg Am; 2015 Dec; 97(24):2032-7. PubMed ID: 26677237
[TBL] [Abstract][Full Text] [Related]
6. NSAIDs for Prophylaxis for Heterotopic Ossification After Total Hip Arthroplasty: A Bayesian Network Meta-analysis.
Migliorini F; Trivellas A; Eschweiler J; Driessen A; Tingart M; Maffulli N
Calcif Tissue Int; 2021 Feb; 108(2):196-206. PubMed ID: 33044630
[TBL] [Abstract][Full Text] [Related]
7. Selective COX-2 Inhibitors Significantly Reduce the Occurrence of Heterotopic Ossification After Hip Arthroscopic Surgery.
Rath E; Warschawski Y; Maman E; Dolkart O; Sharfman ZT; Salai M; Amar E
Am J Sports Med; 2016 Mar; 44(3):677-81. PubMed ID: 26695395
[TBL] [Abstract][Full Text] [Related]
8. The influence of heterotopic ossification on functional status of hip joint following total hip arthroplasty.
Pohl F; Seufert J; Tauscher A; Lehmann H; Springorum HW; Flentje M; Koelbl O
Strahlenther Onkol; 2005 Aug; 181(8):529-33. PubMed ID: 16044221
[TBL] [Abstract][Full Text] [Related]
9. Chemoprophylaxis for heterotopic ossification following hip arthroscopy: A systematic review.
Dean RS; Hamama BA; Cavinatto L; Nho SJ; Chahla J; Hinckel BB
J ISAKOS; 2023 Dec; 8(6):484-489. PubMed ID: 37619960
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial comparing early postoperative irradiation vs. the use of nonsteroidal antiinflammatory drugs for prevention of heterotopic ossification following prosthetic total hip replacement.
Kölbl O; Knelles D; Barthel T; Kraus U; Flentje M; Eulert J
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):961-6. PubMed ID: 9392532
[TBL] [Abstract][Full Text] [Related]
11. Diclofenac for prophylaxis of heterotopic ossification after hip arthroplasty: a systematic review.
Haffer H; Müller M; Ascherl R; Perka C; Winkler T
Hip Int; 2022 Mar; 32(2):144-151. PubMed ID: 33272062
[TBL] [Abstract][Full Text] [Related]
12. Incidence of heterotopic ossification following hip arthroscopy is low: considerations for routine prophylaxis.
Arshad Z; Maughan HD; Garner M; Ali E; Khanduja V
Int Orthop; 2022 Jul; 46(7):1489-1500. PubMed ID: 35482060
[TBL] [Abstract][Full Text] [Related]
13. [Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy].
Kölbl O; Flentje M; Eulert J; Barthel T; Knelles D; Kraus U
Strahlenther Onkol; 1997 Dec; 173(12):677-82. PubMed ID: 9454352
[TBL] [Abstract][Full Text] [Related]
14. Naproxen in the prevention of heterotopic ossification after total hip replacement.
Vielpeau C; Joubert JM; Hulet C
Clin Orthop Relat Res; 1999 Dec; (369):279-88. PubMed ID: 10611883
[TBL] [Abstract][Full Text] [Related]
15. Preoperative irradiation versus the use of nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement: the results of a randomized trial.
Kölbl O; Knelles D; Barthel T; Raunecker F; Flentje M; Eulert J
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):397-401. PubMed ID: 9788422
[TBL] [Abstract][Full Text] [Related]
16. The role of radiation dose in a combined therapeutic protocol for the prevention of heterotopic ossification after total hip replacement.
Pakos EE; Tsekeris PG; Paschos NK; Pitouli EJ; Motsis EK; Xenakis TA
J BUON; 2010; 15(1):74-8. PubMed ID: 20414931
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive update on the pharmacological management of heterotopic ossification following hip arthroplasty: a level I evidenced based expert opinion.
Migliorini F; Asparago G; Oliva F; Cuozzo F; Maffulli N
Expert Opin Pharmacother; 2022 Jul; 23(10):1195-1203. PubMed ID: 35698796
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis.
Kan SL; Yang B; Ning GZ; Chen LX; Li YL; Gao SJ; Chen XY; Sun JC; Feng SQ
Medicine (Baltimore); 2015 May; 94(18):e828. PubMed ID: 25950691
[TBL] [Abstract][Full Text] [Related]
19. Selective versus non-selective NSAIDs as prophylaxis for heterotopic ossification following hip arthroplasty: a meta-analysis.
Migliorini F; Pintore A; Baroncini A; Pastor T; Hildebrand F; Maffulli N
J Orthop Traumatol; 2022 Jul; 23(1):30. PubMed ID: 35809109
[TBL] [Abstract][Full Text] [Related]
20. [Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials].
Xu BG; Xue DT; Wang XH; Yan SG
Zhongguo Gu Shang; 2014 Jul; 27(7):609-14. PubMed ID: 25338452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
